MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'generic drug'. Sat, 03 Sep 2011 03:32:54 +0100 http://www.medworm.com/index.php?rid=4322509&cid=t_238103_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fwhat%25e2%2580%2599s-wrong-it%25e2%2580%2599s-a-generic-drug-rip-off-thats-what%2F2011.01.07 Cute packaging and product placement in the checkout lane at Duane Reade will get you generic Tylenol for a price equivalent to $50 for 100 tabs, as opposed to $6 per 100 count in the usual package. *This blog post was originally published at tbtam* (Source: Better Health) Better Health blogs http://www.medworm.com/rss/comments.php?id=4322509 Fri, 07 Jan 2011 16:00:26 +0100 4322509 http://www.medworm.com/index.php?rid=3994341&cid=t_238103_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FFSDEMvk3Izg%2F Last week, the FDA held its first open meeting about user fees for generic drug makers, an issue that has been around nearly 20 years. The session came as generics continue to grow in popularity – nearly 75 percent of prescription drug volume was generic last year – and the FDA grapples with an inability to approve drugs fast enough. However, the backlog appears to be less of a priority to the agency than having funds to conduct overseas plant inspections. Meanwhile, the generic industry is split – the usual trade group was there along with a new coalition representing a few big players, but Mylan Laboratories spoke for itself. And so we spoke with Ramsey Baghdadi of Provision Policy, a healthcare analysis firm that provides insights to Concept Capital and The RPM Report, about his i... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3994341 Thu, 23 Sep 2010 13:24:17 +0100 3994341 http://www.medworm.com/index.php?rid=3718698&cid=t_238103_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fh68KkPeH3gU%2F Rise and shine, everyone. Another day is on the way. This means, of course, that meetings and deadlines beckon. Never mind that a holiday weekend is just around the corner. To cope, we are brewing the mandatory cup of stimulation, and enjoying an unexpectedly cool breeze. So please join us as we peruse the news of the world. Good luck today and catch you soon… AstraZeneca Loses Bid To Overturn Antitrust Fine (Dow Jones) Biogen Names Exelisis’ George Scangos As CEO (Bloomberg News) Recession Hurts Funding For AIDS Drug Program (New York Times) FDA Issues Latest List Of Drug With Possible Risks (Reuters) Quebec To Cut Generic Drug Prices (PharmaTimes) USPTO Denies Request To Re-Examine Plavix Patent (Dow Jones) Michigan Grows CROs (Xconomy) Calistoga Raises $40M To Fund Drug Tria... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3718698 Thu, 01 Jul 2010 11:56:22 +0100 3718698 http://www.medworm.com/index.php?rid=2512257&cid=t_238103_129_f&fid=36035&url=http%3A%2F%2Fwww.everydayhealth.com%2Fblog%2Flife-with-chronic-pain%2Fnot-all-drug-pushers-are-standing-on-the-corner%2F Many of you, our friends who visit us frequently, have expressed concern and exasperation over all the ads on TV and in magazines from the pharmaceutical companies. They have the pretty girls, the singing birds, the sunshine and very robust individuals extolling the virtues of a particular new drug. Our families and friends seem to be more taken in by the ads than we are. It reminds me of all the candy they sell beside the gossip magazines at the supermarket checkout. The candies are for the kiddies to beg off Mommy and the magazines, well, they’re just trash for the brain. Since the drug companies in this country are the largest lobby group in Washington, they have a lot to sell. When their main line drugs reach the termination age and are allowed to become generic, they lose money.... Life with Chronic Pain blogs http://www.medworm.com/rss/comments.php?id=2512257 Thu, 18 Jun 2009 21:11:49 +0100 2512257